Market Value2,605,471,616
Total Holdings72
File Date2023-08-14
Original Filing (Click here)

All hedge funds or institutions that manage over $100M are required by the SEC to file quarterly reports on their holdings. These reports are called 13F reports. However, the filings are required the following quarter from the reporting period, which means that by the time the filing is made (and we see them), the information could be five months old.

For funds with long term positions that make few trades, the holdings might closely resemble their current holdings, even after several months. However, for funds that have high turnover, the holdings data we see might differ significantly from their current holdings. Institutions are required to report CALL and PUT options, and those positions are identified in the table. However, they are not required to report short positions.

Click the link icon to see the full transaction history.

Upgrade to unlock premium data and export to Excel .

Security Imputed
Share Price
Prev
Shares
Current
Shares
Change
(Percent)
Prev Value
(USD x1000)
Current Value
(USD x1000)
Change
(Percent)
NLTX / Neoleukin Therapeutics, Inc.
SONX / Sonendo, Inc.
IMGN / ImmunoGen, Inc.
AKRO / Akero Therapeutics, Inc.
GRFS / Grifols, S.A. - Depositary Receipt (Common Stock)
FATE / Fate Therapeutics, Inc.
ZBH / Zimmer Biomet Holdings, Inc.
ZYME / Zymeworks Inc.
CLDX / Celldex Therapeutics, Inc.
CABA / Cabaletta Bio, Inc.
XENE / Xenon Pharmaceuticals Inc.
DXCM / DexCom, Inc.
STVN / Stevanato Group S.p.A.
DCPH / Deciphera Pharmaceuticals, Inc.
SLGC / Standard BioTools Inc.
SRPT / Sarepta Therapeutics, Inc.
OSH / Oak Street Health Inc
BMRN / BioMarin Pharmaceutical Inc.
TCRR / Tcr2 Therapeutics Inc
SLRN / Acelyrin, Inc.
CNC / Centene Corporation
/ ONCOLOGY INSTITUTE INC/THE
ILMN / Illumina, Inc.
ARGX / argenx SE - Depositary Receipt (Common Stock)
JAZZ / Jazz Pharmaceuticals plc
LVTX / LAVA Therapeutics N.V.
BSX / Boston Scientific Corporation
PEN / Penumbra, Inc.
KYMR / Kymera Therapeutics, Inc.
BEAM / Beam Therapeutics Inc.
SRRK / Scholar Rock Holding Corporation
MDVL / MedAvail Holdings, Inc.
HOOK / HOOKIPA Pharma Inc.
BMY / Bristol-Myers Squibb Company
ACHL / Achilles Therapeutics plc - Depositary Receipt (Common Stock)
MRSN / Mersana Therapeutics, Inc.
TKNO / Alpha Teknova, Inc.
CTSO / Cytosorbents Corporation
EVH / Evolent Health, Inc.
ISEE / IVERIC bio Inc
ELV / Elevance Health, Inc.
ANNX / Annexon, Inc.
HUM / Humana Inc.
VTYX / Ventyx Biosciences, Inc.
IQV / IQVIA Holdings Inc.
ADCT / ADC Therapeutics SA
STTK / Shattuck Labs, Inc.
ATRA / Atara Biotherapeutics, Inc.
LIVN / LivaNova PLC
IVVD / Invivyd, Inc.
COGT / Cogent Biosciences, Inc.
NVTA / Invitae Corporation
ADAP / Adaptimmune Therapeutics plc - Depositary Receipt (Common Stock)
ALVR / AlloVir, Inc.
KRYS / Krystal Biotech, Inc.
STXS / Stereotaxis, Inc.
ALLK / Allakos Inc.
FOLD / Amicus Therapeutics, Inc.
ALXO / ALX Oncology Holdings Inc.
ETNB / 89bio, Inc.
RGNX / REGENXBIO Inc.
CRL / Charles River Laboratories International, Inc.
XERS / Xeris Biopharma Holdings, Inc.
LSAQ / LifeSci Acquisition II Corp
BCEL / Atreca, Inc.
PLRX / Pliant Therapeutics, Inc.
IGMS / IGM Biosciences, Inc.
AUGX / Augmedix, Inc.
VERV / Verve Therapeutics, Inc.
REPL / Replimune Group, Inc.
CTLT / Catalent, Inc.
SYK / Stryker Corporation
NRIX / Nurix Therapeutics, Inc.
IMVT / Immunovant, Inc.
GRTSQ / Gritstone bio, Inc.
NUVB / Nuvation Bio Inc.
RPTX / Repare Therapeutics Inc.
ABSI / Absci Corporation
TRDA / Entrada Therapeutics, Inc.
STOK / Stoke Therapeutics, Inc.
RAPT / RAPT Therapeutics, Inc.
PRME / Prime Medicine, Inc.